Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ENZL
iShares MSCI New Zealand ETF
$45.85
+0.4%
$45.57
$38.93
$50.41
$73.36M0.865,669 shs7,535 shs
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
$34.58
+0.1%
$32.61
$22.91
$35.19
$84.72M1.14118,676 shs116,548 shs
FLAU
Franklin FTSE Australia ETF
$31.96
+0.2%
$31.24
$24.41
$32.28
$73.51M1.068,432 shs2,696 shs
RAYE
Rayliant Quantamental Emerging Market Equity ETF
$27.38
-0.1%
$26.42
$20.10
$27.50
$76.66M0.5611,232 shs2,532 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ENZL
iShares MSCI New Zealand ETF
0.00%-0.13%-0.02%+1.17%-5.07%
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
0.00%+1.32%+2.64%+17.44%+34.29%
FLAU
Franklin FTSE Australia ETF
0.00%+0.76%+1.85%+5.35%+7.84%
RAYE
Rayliant Quantamental Emerging Market Equity ETF
0.00%+1.26%+2.85%+11.52%+5.55%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ENZL
iShares MSCI New Zealand ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
N/AN/AN/AN/AN/AN/AN/AN/A
FLAU
Franklin FTSE Australia ETF
N/AN/AN/AN/AN/AN/AN/AN/A
RAYE
Rayliant Quantamental Emerging Market Equity ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ENZL
iShares MSCI New Zealand ETF
0.00
N/AN/AN/A
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
2.72
Moderate Buy$34.58N/A
FLAU
Franklin FTSE Australia ETF
0.00
N/AN/AN/A
RAYE
Rayliant Quantamental Emerging Market Equity ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ENZL
iShares MSCI New Zealand ETF
N/AN/AN/AN/AN/AN/A
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
N/AN/AN/AN/AN/AN/A
FLAU
Franklin FTSE Australia ETF
N/AN/AN/AN/AN/AN/A
RAYE
Rayliant Quantamental Emerging Market Equity ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ENZL
iShares MSCI New Zealand ETF
N/AN/A41.58N/AN/AN/AN/AN/A
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
N/AN/A30.34N/AN/AN/AN/AN/A
FLAU
Franklin FTSE Australia ETF
N/AN/A20.41N/AN/AN/AN/AN/A
RAYE
Rayliant Quantamental Emerging Market Equity ETF
N/AN/A14.50N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ENZL
iShares MSCI New Zealand ETF
$1.052.29%N/AN/AN/A
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
$0.250.72%N/AN/AN/A
FLAU
Franklin FTSE Australia ETF
$1.043.25%N/AN/AN/A
RAYE
Rayliant Quantamental Emerging Market Equity ETF
$0.853.10%N/AN/AN/A

Latest FLAU, ENZL, FFTY, and RAYE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
ENZL
iShares MSCI New Zealand ETF
$0.43536/16/20256/16/20256/20/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
ENZL
iShares MSCI New Zealand ETF
147,0001.60 millionN/AOptionable
Innovator IBD 50 ETF stock logo
FFTY
Innovator IBD 50 ETF
N/A2.45 millionN/ANot Optionable
FLAU
Franklin FTSE Australia ETF
N/A2.30 millionN/ANot Optionable
RAYE
Rayliant Quantamental Emerging Market Equity ETF
N/A2.80 millionN/ANot Optionable

Recent News About These Companies

(RAYE) Pivots Trading Plans and Risk Controls
(RAYE) Proactive Strategies
Rayliant Quantamental China Equity ETF
Rayliant Adds Active Japan ETF to Lineup

New MarketBeat Followers Over Time

Media Sentiment Over Time

iShares MSCI New Zealand ETF NASDAQ:ENZL

$45.85 +0.17 (+0.37%)
As of 03:46 PM Eastern

The iShares MSCI New Zealand ETF (ENZL) is an exchange-traded fund that is based on the MSCI New Zeland IMI 25-50 index. The fund tracks the performance of a market-cap-weighted index of equity securities in the top 99% of the New Zealand equity market. ENZL was launched on Sep 1, 2010 and is managed by BlackRock.

Innovator IBD 50 ETF stock logo

Innovator IBD 50 ETF NYSEARCA:FFTY

$34.58 +0.04 (+0.12%)
Closing price 04:10 PM Eastern
Extended Trading
$34.58 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.

Franklin FTSE Australia ETF NYSEARCA:FLAU

$31.96 +0.06 (+0.19%)
As of 04:10 PM Eastern

The Franklin FTSE Australia ETF (FLAU) is an exchange-traded fund that is based on the FTSE Australia RIC Capped index. The fund tracks a market cap-weighted index of large- and mid-cap Australian stocks. FLAU was launched on Nov 2, 2017 and is managed by Franklin Templeton.

Rayliant Quantamental Emerging Market Equity ETF NYSEARCA:RAYE

$27.38 -0.02 (-0.07%)
As of 04:10 PM Eastern

The Rayliant Quantamental Emerging Market Equity ETF (RAYE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed portfolio of emerging market equities that are selected and weighted using a combination of quantitative and fundamental, quantamental, proprietary research. RAYE was launched on Dec 15, 2021 and is managed by Rayliant.